Andre-Jacques Auberton-Herve

Insider Reports History

Location
La Tronche, France
Signature
/s/ Andre-Jacques Auberton-Herve
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Andre-Jacques Auberton-Herve:

Company Role Class Num Shares Value Price $ Report Date Ownership
Chavant Capital Acquisition Corp. Director Class A Common Stock 540,966 $5,409,660 $10.00 21 Dec 2023 Indirect
Bionik Laboratories Corp. Director Common Stock 1,109,271 $665,563 $0.6000 13 Jun 2023 Shares held through Star SCI
Chavant Capital Acquisition Corp. Director Class A Common Stock 27,826 $278,260 $10.00 21 Dec 2023 Direct
Bionik Laboratories Corp. Director Common Stock 95,149 $57,089 $0.6000 13 Jun 2023 Direct
Bionik Laboratories Corp. Director Common Stock 10,693 $6,416 $0.6000 13 Jun 2023 Shares held through 4A Consulting and Engineering
Chavant Capital Acquisition Corp. Director Make-Whole Shares (right to acquire) 145,335 21 Dec 2023 Indirect
Bionik Laboratories Corp. Director Convertible Promissory Note 1 13 Jun 2023 Through Star SCI

Insider Reports Filed by Andre-Jacques Auberton-Herve

Symbol Company Period Transactions Value $ Form Type Role Filing Time
MOBX Chavant Capital Acquisition Corp. 21 Dec 2023 3 +$1,453,350 4 Director 26 Dec 2023, 17:56
/report/000110465923073231-auberton-herve-andre-jacques-2023-06-13 Bionik Laboratories Corp. 13 Jun 2023 2 +$331,667 4 Director 21 Jun 2023, 10:58
/report/000110465923073228-auberton-herve-andre-jacques-2023-06-09 Bionik Laboratories Corp. 09 Jun 2023 1 +$390,000 4 Director 21 Jun 2023, 10:55
MOBX Chavant Capital Acquisition Corp. 24 Feb 2022 1 $0 4 Director 28 Feb 2022, 10:38
MOBX Chavant Capital Acquisition Corp. 19 Jul 2021 0 $0 3 Director 20 Jul 2021, 18:19
/report/000110465922073086-auberton-herve-andre-jacques-2021-07-15 Bionik Laboratories Corp. 15 Jul 2021 4 +$210,201 4 Director 21 Jun 2022, 17:49